Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Regina Paleski
Ribon Therapeutics, developer of new cancer medicines, chooses a CBO and former Merck & Co. SVP joins cellular therapies firm SQZ Biotech. Meanwhile, Roche promotes global diagnostics VP to President, Roche Diagnostics Canada.
T-cell therapy firm Kite Pharma announces a former Eli Lilly VP as its next CEO. Over at Canadian pharma and cannabis business Tilray, three new VPs for Europe in expansion, marketing and commercial development.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Executives On The Move: EIP Pharma Acquires Talent From Shire, And Arvinas And Selvita Fill Top Medical Spots
CNS-focused therapeutics developer EIP Pharma adds former Shire VP as CFO. And new CMOs for protein-degradation therapeutics firm Arvinas and European drug discovery business Selvita.
Executives On The Move: Amgen Biologics Head Joins Immusoft; Julphar Poaches From Novartis, AbbVie And Mylan
Executives On The Move: Exits At AbbVie And Shire Pharma, And A Regional Leadership Appointment At Acino
AbbVie medical exec now holds CMO position at vaccines company Vaccitech, and Shire Pharma head of international commercial picked for CEO of protein-misfolding firm Orphazyme. Swiss pharma Acino International appoints former Novartis services head as General Manager, Latin America.